Spartha Medical

SPARTHA Medical is a Deeptech company created in 2019. With our 20 years of experience in biomaterials and bioengineering, we have developed an innovative technology with multifunctional properties including antimicrobial, antiviral and anti-inflammatory activities.

The technology is a formulation/coating made to promote healing and prevent a wide range of bacterial, viral and fungi infections/contaminations. 

The versatility of our coating allows us to address several markets in both medical and consumer sectors with B2B and B2C product and service offerings. Several medical (orthopedics, wound care, general and specific surgery) and non-medical (cosmetics, electronics) multinationals already trust us. And we are currently expanding into the veterinary, food and textile sectors.

Our business model is as follows:

1- SHIELD service : The Shield service includes 4 types of activity as follow :

• Tests & Coating on catalogue : Here we perform several tests and we offer a coating service that are already defined in our catalogue. The tests include, but are not limited to antimicrobial activity, contamination tests,  biocompatibility, accelerated aging tests, etc.
• Tailor-made Tests & Coating : This service include all the testing and coating activity that are not yet on our catalogue and that we design according to our client needs. 

2- SHIELD+ service : This service include co-development, subcontracting of coating production, technology transfer or licensing. Here, we can support our customers in their industrialisation process. In this specific case, other activities are handled by the SPARTHA Medical team, such as regulatory analysis, market analysis, patent analysis, or contact with the authorisation bodies. 

3- Products : SPARTHA offers an antimicrobial and anti-inflammatory coating in kit form (spray gun + cartridge) for use by surgeons during surgery directly on open wounds. A consumer version of the spray is also under development.

SPARTHA Medical's ambition is to customize the interfaces of implants and products subject to and/or vectors of contamination in order to improve their functionality for a better response to bacterial and/or viral invasions.